ClearPoint Neuro (CLPT) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

CLPT Stock Forecast

ClearPoint Neuro stock forecast is as follows: an average price target of $12.00 (represents a 9.49% upside from CLPT’s last price of $10.96) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.

CLPT Price Target

The average price target for ClearPoint Neuro (CLPT) is $12.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $15.00 to $9.00. This represents a potential 9.49% upside from CLPT's last price of $10.96.

CLPT Analyst Ratings

Buy

According to 1 Wall Street analysts, ClearPoint Neuro's rating consensus is 'Buy'. The analyst rating breakdown for CLPT stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

ClearPoint Neuro Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 27, 2024	Frank Takkinen	Loop Capital Markets	$15.00	$12.60	19.00%	36.86%
Mar 13, 2024	Mathew Blackman	Stifel Nicolaus	$9.00	$7.17	25.52%	-17.88%

Row per page

Go to

The latest ClearPoint Neuro stock forecast, released on Aug 27, 2024 by Frank Takkinen from Loop Capital Markets, set a price target of $15.00, which represents a 19.00% increase from the stock price at the time of the forecast ($12.60), and a 36.86% increase from CLPT last price ($10.96).

ClearPoint Neuro Price Target by Period

	1M	3M	12M
# Anlaysts	-	1	2
Avg Price Target	-	$15.00	$12.00
Last Closing Price	$10.96	$10.96	$10.96
Upside/Downside	-100.00%	36.86%	9.49%

In the current month, the average price target of ClearPoint Neuro stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to ClearPoint Neuro's last price of $10.96. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 27, 2024	Lake Street	Buy	Buy	Hold

Row per page

Go to

ClearPoint Neuro's last stock rating was published by Lake Street on Aug 27, 2024. The company gave CLPT a "Buy" rating, the same as its previous rate.

ClearPoint Neuro Financial Forecast

ClearPoint Neuro Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Mar 16	Mar 15	Jun 14	Mar 13	Sep 12
Revenue	-	-	-	-	-	-	-	-	$6.81M	$5.76M	$5.95M	$5.43M	$5.17M	$5.15M	$5.20M	$5.03M	$4.28M	$4.57M	$3.41M	$4.03M	$3.72M	$3.52M	$2.48M	$3.12M	$1.39M	$1.01M	$1.19M	$1.26M	$1.13M
Avg Forecast	$9.67M	$9.66M	$9.26M	$8.51M	$8.23M	$7.77M	$7.33M	$6.99M	$6.53M	$6.73M	$5.90M	$5.00M	$5.20M	$5.40M	$5.08M	$4.18M	$4.30M	$4.00M	$3.69M	$3.27M	$3.24M	$2.47M	$1.88M	$3.54M	$27.98K	$27.66K	$39.13K	$1.26M	$2.26M
High Forecast	$10.13M	$10.11M	$9.70M	$8.91M	$8.56M	$7.77M	$7.33M	$6.99M	$6.94M	$6.73M	$6.18M	$5.24M	$5.45M	$5.40M	$5.08M	$4.18M	$4.30M	$4.00M	$3.69M	$3.27M	$3.24M	$2.47M	$1.88M	$3.54M	$33.58K	$33.20K	$46.96K	$1.52M	$2.72M
Low Forecast	$9.19M	$9.18M	$8.80M	$8.09M	$7.89M	$7.77M	$7.33M	$6.99M	$6.12M	$6.73M	$5.61M	$4.75M	$4.94M	$5.40M	$5.08M	$4.18M	$4.30M	$4.00M	$3.69M	$3.27M	$3.24M	$2.47M	$1.88M	$3.54M	$22.38K	$22.13K	$31.31K	$1.01M	$1.81M
# Analysts	1	1	1	1	2	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	8	20	17	16	8
Surprise %	-	-	-	-	-	-	-	-	1.04%	0.86%	1.01%	1.09%	0.99%	0.95%	1.02%	1.20%	1.00%	1.14%	0.93%	1.23%	1.15%	1.43%	1.32%	0.88%	49.82%	36.53%	30.38%	1.00%	0.50%

ClearPoint Neuro's average Quarter revenue forecast for Mar 24 based on 1 analysts is $6.99M, with a low forecast of $6.99M, and a high forecast of $6.99M. CLPT's average Quarter revenue forecast represents a 2.70% increase compared to the company's last Quarter revenue of $6.81M (Dec 23).

ClearPoint Neuro EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Mar 16	Mar 15	Jun 14	Mar 13	Sep 12
# Analysts	1	1	1	1	2	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	8	20	17	16	8
EBITDA	-	-	-	-	-	-	-	-	$-4.28M	$-4.90M	$-7.13M	$-5.44M	$-4.32M	$-3.79M	$-3.98M	$-3.63M	$-3.94M	$-3.69M	$-3.46M	$-2.19M	$-1.21M	$-1.23M	$-1.41M	$-1.18M	$-1.65M	$-3.55M	$-1.20M	$-729.75K	$-892.51K
Avg Forecast	$-6.14M	$-6.13M	$-5.88M	$-5.40M	$-5.23M	$-4.93M	$-4.66M	$-4.44M	$-4.15M	$-4.27M	$-3.75M	$-3.18M	$-3.30M	$-3.43M	$-3.23M	$-4.18M	$-2.73M	$-2.54M	$-2.34M	$-2.21M	$-2.06M	$-1.57M	$-1.19M	$-1.48M	$-1.65M	$-2.80M	$-1.49M	$-603.49K	$-1.20M
High Forecast	$-5.84M	$-5.83M	$-5.59M	$-5.14M	$-5.01M	$-4.93M	$-4.66M	$-4.44M	$-3.89M	$-4.27M	$-3.56M	$-3.02M	$-3.14M	$-3.43M	$-3.23M	$-3.34M	$-2.73M	$-2.54M	$-2.34M	$-1.76M	$-2.06M	$-1.57M	$-1.19M	$-1.18M	$-1.32M	$-2.24M	$-1.20M	$-482.79K	$-963.91K
Low Forecast	$-6.43M	$-6.42M	$-6.16M	$-5.66M	$-5.44M	$-4.93M	$-4.66M	$-4.44M	$-4.41M	$-4.28M	$-3.92M	$-3.33M	$-3.46M	$-3.43M	$-3.23M	$-5.01M	$-2.73M	$-2.54M	$-2.34M	$-2.65M	$-2.06M	$-1.57M	$-1.19M	$-1.78M	$-1.98M	$-3.36M	$-1.79M	$-724.19K	$-1.45M
Surprise %	-	-	-	-	-	-	-	-	1.03%	1.15%	1.90%	1.71%	1.31%	1.11%	1.23%	0.87%	1.44%	1.45%	1.48%	0.99%	0.59%	0.78%	1.18%	0.80%	1.00%	1.27%	0.80%	1.21%	0.74%

undefined analysts predict CLPT's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than ClearPoint Neuro's previous annual EBITDA (undefined) of $NaN.

ClearPoint Neuro Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Mar 16	Mar 15	Jun 14	Mar 13	Sep 12
# Analysts	1	1	1	1	2	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	8	20	17	16	8
Net Income	-	-	-	-	-	-	-	-	$-4.62M	$-4.81M	$-7.05M	$-5.39M	$-4.30M	$-3.78M	$-4.40M	$-4.05M	$-4.31M	$-3.98M	$-3.74M	$-2.54M	$-1.58M	$-1.48M	$-1.66M	$-2.05M	$-2.04M	$-3.95M	$-1.59M	$-950.00K	$-1.07M
Avg Forecast	$-3.72M	$-3.72M	$-4.00M	$-4.41M	$-4.52M	$-4.78M	$-5.43M	$-5.24M	$-5.61M	$-6.90M	$-5.24M	$-5.24M	$-5.52M	$-5.22M	$-5.09M	$-4.55M	$-5.22M	$-4.39M	$-3.71M	$-2.72M	$-3.57M	$-3.85M	$-4.39M	$-2.63M	$-2.04M	$-3.11M	$-1.99M	$-823.75K	$-1.45M
High Forecast	$-3.49M	$-3.49M	$-3.74M	$-4.13M	$-3.62M	$-4.47M	$-5.08M	$-4.91M	$-4.85M	$-6.46M	$-4.91M	$-4.91M	$-5.16M	$-5.22M	$-5.09M	$-3.64M	$-5.22M	$-4.39M	$-3.71M	$-2.18M	$-3.57M	$-3.85M	$-4.39M	$-2.10M	$-1.64M	$-2.49M	$-1.59M	$-659.00K	$-1.16M
Low Forecast	$-3.95M	$-3.95M	$-4.25M	$-4.69M	$-5.43M	$-5.07M	$-5.76M	$-5.56M	$-6.12M	$-7.32M	$-5.56M	$-5.56M	$-5.86M	$-5.22M	$-5.09M	$-5.46M	$-5.22M	$-4.39M	$-3.71M	$-3.26M	$-3.57M	$-3.85M	$-4.39M	$-3.15M	$-2.45M	$-3.73M	$-2.39M	$-988.50K	$-1.74M
Surprise %	-	-	-	-	-	-	-	-	0.82%	0.70%	1.35%	1.03%	0.78%	0.72%	0.87%	0.89%	0.83%	0.91%	1.01%	0.93%	0.44%	0.39%	0.38%	0.78%	1.00%	1.27%	0.80%	1.15%	0.74%

ClearPoint Neuro's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CLPT's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

ClearPoint Neuro SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Mar 16	Mar 15	Jun 14	Mar 13	Sep 12
# Analysts	1	1	1	1	2	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	8	20	17	16	8
SG&A	-	-	-	-	-	-	-	-	$6.07M	$5.74M	$6.65M	$5.89M	$4.16M	$5.05M	$5.18M	$4.58M	$4.54M	$4.26M	$3.57M	$3.23M	$2.72M	$2.86M	$2.49M	$2.58M	$1.97M	$2.29M	$1.93M	$1.63M	$1.44M
Avg Forecast	$8.78M	$8.77M	$8.41M	$7.72M	$7.47M	$7.05M	$6.66M	$6.35M	$5.93M	$6.11M	$5.36M	$4.54M	$4.72M	$4.90M	$4.61M	$3.80M	$3.90M	$3.63M	$3.35M	$2.97M	$2.94M	$2.24M	$1.70M	$3.29M	$25.40K	$25.11K	$35.53K	$1.15M	$1.95M
High Forecast	$9.19M	$9.18M	$8.81M	$8.09M	$7.77M	$7.05M	$6.66M	$6.35M	$6.30M	$6.11M	$5.61M	$4.75M	$4.94M	$4.90M	$4.61M	$3.80M	$3.90M	$3.63M	$3.35M	$2.97M	$2.94M	$2.24M	$1.70M	$3.95M	$30.48K	$30.14K	$42.63K	$1.38M	$2.34M
Low Forecast	$8.34M	$8.33M	$7.99M	$7.34M	$7.16M	$7.05M	$6.66M	$6.35M	$5.56M	$6.11M	$5.09M	$4.32M	$4.49M	$4.90M	$4.61M	$3.80M	$3.90M	$3.63M	$3.35M	$2.97M	$2.94M	$2.24M	$1.70M	$2.63M	$20.32K	$20.09K	$28.42K	$918.18K	$1.56M
Surprise %	-	-	-	-	-	-	-	-	1.02%	0.94%	1.24%	1.30%	0.88%	1.03%	1.12%	1.21%	1.16%	1.17%	1.07%	1.09%	0.93%	1.28%	1.46%	0.78%	77.72%	91.13%	54.30%	1.42%	0.74%

ClearPoint Neuro's average Quarter SG&A projection for Mar 24 is $6.35M, based on 1 Wall Street analysts, with a range of $6.35M to $6.35M. The forecast indicates a 4.65% rise compared to CLPT last annual SG&A of $6.07M (Dec 23).

ClearPoint Neuro EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Mar 16	Mar 15	Jun 14	Mar 13	Sep 12
# Analysts	1	1	1	1	2	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	8	20	17	16	8
EPS	-	-	-	-	-	-	-	-	$-0.19	$-0.20	$-0.00	$-0.22	$-0.18	$-0.15	$-0.18	$-0.17	$-0.19	$-0.18	$-0.17	$-0.13	$-0.09	$-0.09	$-0.11	$-0.13	$-0.80	$-2.00	$-1.20	$-0.80	$-0.80
Avg Forecast	$-0.14	$-0.14	$-0.14	$-0.16	$-0.16	$-0.17	$-0.20	$-0.19	$-0.20	$-0.25	$-0.19	$-0.19	$-0.20	$-0.19	$-0.19	$-0.20	$-0.19	$-0.16	$-0.14	$-0.14	$-0.13	$-0.14	$-0.16	$-0.18	$-0.80	$-0.95	$-2.00	$-0.80	$-2.16
High Forecast	$-0.13	$-0.13	$-0.14	$-0.15	$-0.13	$-0.16	$-0.18	$-0.18	$-0.18	$-0.23	$-0.18	$-0.18	$-0.19	$-0.19	$-0.19	$-0.20	$-0.19	$-0.16	$-0.14	$-0.14	$-0.13	$-0.14	$-0.16	$-0.18	$-0.64	$-0.76	$-1.60	$-0.64	$-1.73
Low Forecast	$-0.14	$-0.14	$-0.15	$-0.17	$-0.20	$-0.18	$-0.21	$-0.20	$-0.22	$-0.27	$-0.20	$-0.20	$-0.21	$-0.19	$-0.19	$-0.20	$-0.19	$-0.16	$-0.14	$-0.14	$-0.13	$-0.14	$-0.16	$-0.18	$-0.96	$-1.13	$-2.40	$-0.96	$-2.59
Surprise %	-	-	-	-	-	-	-	-	0.93%	0.80%	0.00%	1.16%	0.90%	0.79%	0.97%	0.85%	1.00%	1.13%	1.26%	0.90%	0.69%	0.64%	0.69%	0.72%	1.00%	2.11%	0.60%	1.00%	0.37%

According to undefined Wall Street analysts, ClearPoint Neuro's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CLPT previous annual EPS of $NaN (undefined).

ClearPoint Neuro Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
OM	Outset Medical	$0.73	$11.00	1406.85%	Buy
CTSO	Cytosorbents	$0.92	$9.00	878.26%	-
APYX	Apyx Medical	$1.40	$8.50	507.14%	Buy
TELA	TELA Bio	$2.90	$12.50	331.03%	Buy
INGN	Inogen	$9.46	$26.00	174.84%	Buy
SGHT	Sight Sciences	$3.73	$9.00	141.29%	Hold
LUNG	Pulmonx	$6.20	$11.93	92.42%	Buy
KIDS	OrthoPediatrics	$25.50	$39.60	55.29%	Buy
LIVN	LivaNova	$50.05	$70.50	40.86%	Buy
NPCE	NeuroPace	$9.19	$12.88	40.15%	Buy
NARI	Inari Medical	$49.00	$66.11	34.92%	Buy
INSP	Inspire Medical Systems	$184.77	$239.55	29.65%	Buy
CLPT	ClearPoint Neuro	$10.96	$12.00	9.49%	Buy
SRDX	Surmodics	$39.17	$39.50	0.84%	Buy
SWAV	ShockWave Medical	$334.75	$258.17	-22.88%	Hold
RCEL	AVITA Medical	$13.05	$9.00	-31.03%	Buy

CLPT Forecast FAQ

Is ClearPoint Neuro a good buy?

Yes, according to 1 Wall Street analysts, ClearPoint Neuro (CLPT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of CLPT's total ratings.

What is CLPT's price target?

ClearPoint Neuro (CLPT) average price target is $12 with a range of $9 to $15, implying a 9.49% from its last price of $10.96. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will ClearPoint Neuro stock go up soon?

According to Wall Street analysts' prediction for CLPT stock, the company can go up by 9.49% (from the last price of $10.96 to the average price target of $12), up by 36.86% based on the highest stock price target, and down by -17.88% based on the lowest stock price target.

Can ClearPoint Neuro stock reach $20?

CLPT's average twelve months analyst stock price target of $12 does not support the claim that ClearPoint Neuro can reach $20 in the near future.

What are ClearPoint Neuro's analysts' financial forecasts?

ClearPoint Neuro's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $30.32M (high $30.66M, low $29.98M), average EBITDA is $-19.26M (high $-19.042M, low $-19.471M), average net income is $-19.973M (high $-18.078M, low $-21.827M), average SG&A $27.53M (high $27.83M, low $27.22M), and average EPS is $-0.724 (high $-0.655, low $-0.791). CLPT's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $37.09M (high $38.85M, low $35.26M), average EBITDA is $-23.559M (high $-22.398M, low $-24.674M), average net income is $-15.865M (high $-14.848M, low $-16.841M), average SG&A $33.68M (high $35.27M, low $32.01M), and average EPS is $-0.575 (high $-0.538, low $-0.61).

Did the CLPT's actual financial results beat the analysts' financial forecasts?

Based on ClearPoint Neuro's last annual report (Dec 2023), the company's revenue was $23.96M, which missed the average analysts forecast of $24.16M by -0.86%. Apple's EBITDA was $-22.446M, beating the average prediction of $-15.348M by 46.25%. The company's net income was $-22.089M, missing the average estimation of $-22.993M by -3.93%. Apple's SG&A was $24.35M, beating the average forecast of $21.94M by 11.00%. Lastly, the company's EPS was $-0.0009, missing the average prediction of $-0.833 by -99.89%. In terms of the last quarterly report (Dec 2023), ClearPoint Neuro's revenue was $6.81M, beating the average analysts' forecast of $6.53M by 4.23%. The company's EBITDA was $-4.282M, beating the average prediction of $-4.15M by 3.19%. ClearPoint Neuro's net income was $-4.619M, missing the average estimation of $-5.61M by -17.67%. The company's SG&A was $6.07M, beating the average forecast of $5.93M by 2.29%. Lastly, the company's EPS was $-0.19, missing the average prediction of $-0.203 by -6.56%